Skip to main content
Clinical Trials/NCT02023190
NCT02023190UnknownNot Applicable

Changes in Body Composition and Nutritional Status Assessed by Bioelectrical Impedance Vector Analysis in Cirrhotic Patients Undergoing Liver Transplantation

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1 site in 1 country60 target enrollmentStarted: January 3, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Body composition

Study Overview

Brief Summary

Liver transplant is the goal treatment for every patient with end-stage chronic liver disease.

Quality of life improves after transplant because the main complications of end-stage liver disease disappear, but due to immunosuppression other alterations appear such as metabolic alterations, weight gain, among others.

Body composition and nutritional status can be affected do to post-transplant pharmacologic therapy.

Detailed Description

Body composition and nutritional status can be affected due to post-transplant pharmacologic therapy.

This is a prospective cohort study, patients from liver transplant waiting list will be assessed, pre and post-transplant measures of body composition and nutritional status will be obtained.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Liver cirrhosis (any etiology)
  • Enrolled in waiting list for tliver transplant

Exclusion Criteria

  • Hepatocellular carcinoma
  • Chronic renal failure
  • Congestive cardiac failure
  • Extremity amputation
  • Pregnancy

Outcomes

Primary Outcomes

Body composition

Time Frame: Baseline, 7 days, 1 month, 3 months and 6 months post-tranpslant

Body composition will be assessed through bioelectrical impedance vector analysis graph.

Secondary Outcomes

  • Liver function tests(Baseline, 7 days, 1 month, 3 months and 6 months post-tranpslant)

Investigators

Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

ALDO TORRE DELGADILLO

Principal investigator

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Study Sites (1)

Loading locations...

Similar Trials